Loncastuximab tesirine

Therapeutic Loncastuximab tesirine ADC from the original Zynlonta® commercial drug.

Showing the single result

Filter our product list:
API
Antigen / Target
Therapeutic Areas
Therapeutic Indications
Classes of molecule​s
Isotypes
Expiry Date
CoA
Filters Sort results
Reset Apply

Product
Batch

Antigen
Molecular Class
Drug Brand
Product Concentration
CoA
Quantity per vial
Storage Temperature
Expiry Date
Price from
Loncastuximab tesirine S22E015C
CD19
Antibody-drug conjugate (ADC)
Zynlonta®
5 mg/mL
–
0,5 mg
-80 °C
04/2026
1.856,00 €
view product
Max: 10
Min: 1
Step: 1

Not looking for Loncastuximab tesirine?

Search our therapeutic molecules product database

Evidentic GmbH
Am Mühlenberg 10

14476 Potsdam | Germany

+49 (0) 30 959 99 8831
info@evidentic.com

Cookie Preferences

Linkedin Youtube Facebook Twitter Instagram